SECTOR : Medical devices
ENTRY DATE : 2011
EXIT DATE : 2018
BUSINESS : Venture Capital
An innovative new inferior vena cava filter device to prevent pulmonary embolism
Based in Galway (Ireland), Novate Medical specialises in developing vena cava filters.
Its flagship product, a bioconvertible vena cava filter, is the first of its kind in the world. It is composed of a bioabsorbable material that helps to protect patients at transient high risk of pulmonary embolism. This medical device dispenses with the need for a follow-up procedure to remove the filter, as required for the optional vena cava filters currently available on the market.
PRESS RELEASE(S) :
20/05/2011• Crédit Agricole Private Equity and Seroba Kernel Life Sciences filter an €8.7 million investment into Novate Medical Ltd